Eversept Partners, LP Orchard Therapeutics PLC Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.78 $176,224 - $327,273	-419,581 Closed	0 $0
Q1 2022 Nov 08, 2023	BUY	$0.7 - $1.51 $293,706 - $633,567	419,581 New	419,581 $297,000
Q4 2021 Nov 08, 2023	SELL	$1.16 - $2.23 $174,000 - $334,500	-150,000 Reduced 26.34%	419,581 $553,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $174,000 - $334,500	-150,000 Reduced 26.34%	419,581 $554,000
Q3 2021 Nov 08, 2023	BUY	$2.24 - $4.29 $1.28 Million - $2.44 Million	569,581 New	569,581 $1.31 Million
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $1.28 Million - $2.44 Million	569,581 New	569,581 $1.31 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.